Switching to generic statins may increase cardiovascular event risk: study
Switching from Lipitor to generic simvastatin may lead to less potent doses being used and potentially increase the risk of cardiovascular events, new research suggests.
4 weeks ago0
Health professionals need to question patients over CM use
Many cardiac patients are failing to disclose complementary medicine (CM) use for fear of disapproval by their health professional, research shows.
8 weeks ago0
Cardiovascular polypill wins pharmacist support
A majority of Australian pharmacists would support the use of a cardiovascular polypill as one solution to poor medication compliance,...
Questions over intensive glucose lowering: study
Intensive glucose lowering treatment has no significant benefit on all-cause mortality and cardiovascular-related deaths in patients with type 2 diabetes...
Calcium supplement use increases risk of cardiovascular events
Evidence is mounting that calcium supplements increase the risk of cardiovascular events, particularly myocardial infarction in older women.
Browse our newsletter archive
Advertisement